Enzon Pharmaceuticals Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Rick Feinstein
Chief executive officer
US$224.1k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 10.9yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
CEO
Rick Feinstein (81 yo)
10.9yrs
Tenure
US$224,068
Compensation
Mr. Richard L. Feinstein, also known as Rick, CPA, has been Chief Executive Officer and Secretary at Enzon Pharmaceuticals Inc. since February 26, 2021. He had been Vice President of Finance at Enzon Pharm...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman | 4.3yrs | US$36.67k | 0.27% € 13.7k | |
| Independent Director | 2.4yrs | US$36.67k | no data | |
| Independent Director | 4.3yrs | US$36.67k | 0.13% € 6.8k |
4.3yrs
Average Tenure
69yo
Average Age
Experienced Board: EZ1's board of directors are considered experienced (4.3 years average tenure).